Lakeland Industries Inc. (LAKE)
Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Manufacturing · CIK 798081 · fiscal year ends in Jan
Closing price $8.84 on 30 Oct 2026; 52-week range $7.58 to $16.87.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $191.0M
- Revenue growth
- -0.4%
- Net income, last twelve months
- -$26.7M
- Earnings per share
- -$2.76
- Gross margin
- 32.6%
- Operating margin
- -4.1%
- Net margin
- -14.0%
- Return on equity
- -21.4%
- Market value
- $87.6M
- Cash
- $17.9M
- Debt
- $28.7M
- Debt to equity
- 0.23
- Shares outstanding
- 9.9M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2026 | 31 Jan 2026 | $192.6M | -$15.5M | -$25.3M | -$2.63 | -$16.4M | 10-K filed 16 Apr 2026 |
| FY2025 | 31 Jan 2025 | $167.2M | -$9.3M | -$18.1M | -$2.43 | -$17.4M | 10-K filed 17 Apr 2025 |
| FY2024 | 31 Jan 2024 | $124.7M | $6.0M | $5.4M | $0.72 | $8.8M | 10-K filed 11 Apr 2024 |
| FY2023 | 31 Jan 2023 | $112.8M | $5.5M | $1.9M | $0.24 | -$7.4M | 10-K filed 18 Apr 2023 |
| FY2022 | 31 Jan 2022 | $118.4M | $16.0M | $11.4M | $1.41 | $12.0M | 10-K filed 21 Apr 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2027 | 31 Jul 2026 | $50.1M | -$4.9M | -$0.50 |
| Q1 FY2027 | 30 Apr 2026 | $47.4M | $369.0K | $0.04 |
| Q4 FY2026 | 31 Jan 2026 | $45.8M | -$6.2M | -$0.66 |
| Q3 FY2026 | 31 Oct 2025 | $47.6M | -$16.0M | -$1.64 |
| Q2 FY2026 | 31 Jul 2025 | $52.5M | $766.0K | $0.08 |
| Q1 FY2026 | 30 Apr 2025 | $46.7M | -$3.9M | -$0.41 |
| Q4 FY2025 | 31 Jan 2025 | $46.6M | -$18.4M | -$2.43 |
| Q3 FY2025 | 31 Oct 2024 | $45.8M | $86.0K | $0.01 |
Company events
The newest 8-K filings of 299 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 9 Sep 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 18 Jun 2026 | 8-K | Leadership change, Shareholder vote | 5.02, 5.07, 9.01 |
| 9 Jun 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 16 Apr 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 30 Mar 2026 | 8-K | Material agreement, Investor update | 1.01, 7.01, 9.01 |
| 23 Feb 2026 | 8-K | Leadership change, Investor update | 5.02, 7.01, 9.01 |
| 17 Feb 2026 | 8-K | Investor update | 7.01, 9.01 |
| 17 Feb 2026 | 8-K/A | Leadership change | 5.02 |
| 26 Jan 2026 | 8-K | Investor update | 7.01, 9.01 |
| 9 Jan 2026 | 8-K | Leadership change | 5.02 |
| 9 Dec 2025 | 8-K | Results, Leadership change, Investor update, Other events | 2.02, 5.02, 7.01, 8.01, 9.01 |
| 3 Nov 2025 | 8-K | Other events | 8.01, 9.01 |
Every filing
The newest filings with the SEC of 567 held.
| Filed | Form | Period |
|---|---|---|
| 9 Sep 2026 | 10-Q | 31 Jul 2026 |
| 9 Sep 2026 | 8-K | 9 Sep 2026 |
| 18 Jun 2026 | 8-K | 18 Jun 2026 |
| 16 Jun 2026 | S-8 | – |
| 9 Jun 2026 | 10-Q | 30 Apr 2026 |
| 9 Jun 2026 | 8-K | 9 Jun 2026 |
| 7 May 2026 | ARS | 31 Jan 2026 |
| 7 May 2026 | DEFA14A | – |
| 7 May 2026 | DEF 14A | 16 Jun 2026 |
| 21 Apr 2026 | 10-K/A | 31 Jan 2026 |
| 16 Apr 2026 | 10-K | 31 Jan 2026 |
| 16 Apr 2026 | 8-K | 16 Apr 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 6 May 2026 | Rudow Lee D., Director | Took pay in stock | 5,935 | – | – | – | 8 May 2026 |
| 6 May 2026 | Rudow Lee D., Director | Took pay in stock | 1,780 | – | – | – | 8 May 2026 |
| 6 May 2026 | Glavin Martin G, Director | Took pay in stock | 7,009 | – | – | – | 8 May 2026 |
| 6 May 2026 | Glavin Martin G, Director | Took pay in stock | 2,103 | – | – | – | 8 May 2026 |
| 13 Jan 2026 | Stokes Cameron, See Remarks | Purchase | 450 | $9.43 | $4.2K | 4,758 | 15 Jan 2026 |
| 9 Jan 2026 | Hui An, Chief Operating Officer | Purchase | 2,000 | $8.97 | $17.9K | 72,850 | 12 Jan 2026 |
| 9 Jan 2026 | Swinea James Calven Jr., Interim CFO | Purchase | 1,000 | $8.71 | $8.7K | 7,305 | 9 Jan 2026 |
| 5 Jan 2026 | Jenkins James M., President, CEO & Exec. Chair | Purchase | 1,127 | $8.88 | $10.0K | 94,565 | 5 Jan 2026 |
| 23 Dec 2025 | Phillips Barry G, Chief Revenue Officer - Fire | Purchase | 1,250 | $8.71 | $10.9K | 18,802 | 29 Dec 2025 |
| 22 Dec 2025 | Yartz Laurel A., Chief Human Resources Officer | Purchase | 1,350 | $8.15 | $11.0K | 15,826 | 23 Dec 2025 |
| 19 Dec 2025 | Jenkins James M., President, CEO & Exec. Chair | Purchase | 1,265 | $7.92 | $10.0K | 93,438 | 19 Dec 2025 |
| 16 Dec 2025 | Shannon Roger D, Chief Financial Officer | Sale outside a trading plan | 8,869 | $8.06 | $71.5K | 36,026 | 18 Dec 2025 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 19 Dec 2025 | Shannon Roger D, Officer | 8,869 | $71.5K | 16 Dec 2025 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 29 Jul 2026 | BlackRock, Inc. | 13G amended | 1.6% | 155.3K |
| 22 Jul 2026 | ROYCE & ASSOCIATES LP | 13G amended | 13.37% | 1.3M |
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 6 Feb 2026 | Pacific Ridge Capital Partners, LLC | 13G | 7.9% | 772.0K |
| 21 Jan 2026 | Dimensional Fund Advisors LP | 13G amended | 4.4% | 430.0K |
| 22 Dec 2025 | Global Value Investment Corporation | 13D | 8.38% | 821.9K |
| 11 Dec 2025 | Lempel Brian David | 13G amended | 10% | 974.3K |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 1.1M | -4.61% | 9.09 |
| 30 Sep 2026 | 1.2M | +17.78% | 23.31 |
| 15 Sep 2026 | 1.0M | -14.97% | 14 |
| 31 Aug 2026 | 1.2M | -4.48% | 21.78 |
| 14 Aug 2026 | 1.3M | -4% | 21.58 |
| 31 Jul 2026 | 1.3M | -5.58% | 21.54 |
| 15 Jul 2026 | 1.4M | +8.01% | 17.35 |
| 30 Jun 2026 | 1.3M | -3.71% | 5.74 |
Funds that hold it
From each fund's latest Form 13F.
88 funds held it at 30 Jun 2026: 34 added and 23 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| Royce & Associates LP | 1,319,086 | $14.1M | +105,664 |
| Private Capital Management, LLC | 1,249,274 | $13.4M | -258,949 |
| Pacific Ridge Capital Partners, LLC | 975,881 | $10.4M | +46,900 |
| Vanguard Capital Management LLC | 393,129 | $4.2M | +1,829 |
| Dimensional Fund Advisors LP | 320,235 | $3.4M | -8,909 |
| Morgan Stanley | 268,285 | $2.9M | -615 |
| Marshall Wace, LLP | 234,575 | $2.5M | +234,575 |
| Peapod Lane Capital LLC | 207,657 | $2.2M | +79,539 |
| Renaissance Technologies LLC | 182,802 | $2.0M | -17,600 |
| BlackRock, Inc. | 158,276 | $1.7M | -398,161 |
Peers
Companies in the same industry.
- Intuitive Surgical Inc. (ISRG): revenue $11.6B, market value $149.8B
- Edwards Lifesciences Corp. (EW): revenue $6.5B, market value $53.1B
- Steris plc (STE): revenue $6.0B, market value $22.1B
- Zimmer Biomet Holdings, Inc. (ZBH): revenue $8.5B, market value $18.0B
- Smith & Nephew plc (SNN): revenue $6.2B, market value $13.0B
- Align Technology Inc. (ALGN): revenue $4.1B, market value $10.7B
- MSA Safety Inc. (MSA): revenue $1.9B, market value $6.9B
- Establishment Labs Holdings Inc. (ESTA): revenue $245.8M, market value $1.9B
- Cadre Holdings, Inc. (CDRE): revenue $685.6M, market value $1.3B
- Enovis Corp. (ENOV): revenue $2.3B, market value $1.1B